Back to Search Start Over

Xiang-Qi-Tang and its active components exhibit anti-inflammatory and anticoagulant properties by inhibiting MAPK and NF-κB signaling pathways in LPS-treated rat cardiac microvascular endothelial cells.

Authors :
He, Chang-Liang
Yi, Peng-Fei
Fan, Qiao-Jia
Shen, Hai-Qing
Jiang, Xiao-Lin
Qin, Qian-Qian
Song, Zhou
Zhang, Cui
Wu, Shuai-Cheng
Wei, Xu-Bin
Li, Ying-Lun
Fu, Ben-Dong
Source :
Immunopharmacology & Immunotoxicology; Apr2013, Vol. 35 Issue 2, p215-224, 10p, 1 Color Photograph, 3 Charts, 5 Graphs
Publication Year :
2013

Abstract

Xiang-Qi-Tang (XQT) is a Chinese herbal formula containing Cyperus rotundus, Astragalus membranaceus and Andrographis paniculata. Alpha-Cyperone (CYP), astragaloside IV (AS-IV) and andrographolide (AND) are the three major active components in this formula. XQT may modulate the inflammatory or coagulant responses. We therefore assessed the effects of XQT on lipopolysaccharide (LPS)-induced inflammatory model of rat cardiac microvascular endothelial cells (RCMECs). XQT, CYP, AS-IV and AND inhibited the production of tumor necrosis factor alpha (TNF-α), intercellular cell adhesion molecule-1 (ICAM-1) and plasminogen activator inhibitor-1 (PAI-1), and up-regulated the mRNA expression of Kruppel-like factor 2 (KLF2). XQT and CYP inhibited the secretion of tissue factor (TF). To further explore the mechanism, we found that XQT, or its active components CYP, AS-IV and AND significantly inhibited extracellular signal-regulated kinase (ERK), c-jun NH2-terminal kinase (JNK) and p38 phosphorylation protein expression as well as decreased the phosphorylation levels of nuclear factor κB (NF-κB) p65 proteins in LPS-stimulated RCMECs. These results suggested that XQT and its active components inhibited the expression of inflammatory and coagulant mediators via mitogen-activated protein kinase (MAPKs) and NF-κB signaling pathways. These findings may contribute to future research on the action mechanisms of this formula, as well as therapy for inflammation- or coagulation-related diseases. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
08923973
Volume :
35
Issue :
2
Database :
Complementary Index
Journal :
Immunopharmacology & Immunotoxicology
Publication Type :
Academic Journal
Accession number :
85985725
Full Text :
https://doi.org/10.3109/08923973.2012.744034